BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 25016792)

  • 1. [One year outcomes of pars plana vitrectomy in proliferative diabetic retinopathy].
    Tadera M; Kawamura H; Fujikawa M; Kakinoki M; Sawada T; Saishin Y; Ohji M
    Nippon Ganka Gakkai Zasshi; 2014 Jun; 118(6):502-7. PubMed ID: 25016792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
    Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
    Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Different outcome among eyes with proliferative diabetic retinopathy indicated for vitrectomy].
    Muramatsu M; Yokoi M; Muramatsu A; Saito W; Furudate N; Ohno S
    Nippon Ganka Gakkai Zasshi; 2006 Dec; 110(12):950-60. PubMed ID: 17228758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transconjunctival 25-gauge sutureless vitrectomy and silicone oil injection in diabetic tractional retinal detachment.
    Altan T; Acar N; Kapran Z; Unver YB; Ozdogan S
    Retina; 2008 Oct; 28(9):1201-6. PubMed ID: 18728620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment.
    Tao Y; Jiang YR; Li XX; Gao L; Jonas JB
    Retina; 2010 Mar; 30(3):447-51. PubMed ID: 20216292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of vitreous surgery for proliferative diabetic retinopathy.
    Sima P; Zoran T
    Doc Ophthalmol; 1994; 87(3):223-32. PubMed ID: 7835192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe proliferative diabetic retinopathy treated with vitrectomy or panretinal photocoagulation: a monocenter randomized controlled clinical trial.
    Avitabile T; Bonfiglio V; Castiglione F; Castaing M; Contarino F; Mistretta A
    Can J Ophthalmol; 2011 Aug; 46(4):345-51. PubMed ID: 21816255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vitrectomy and proliferative diabetic retinopathy. Apropos of 66 eyes].
    Bouchard O; Zech JC; Trepsat C
    J Fr Ophtalmol; 1997; 20(4):263-70. PubMed ID: 9181137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual outcomes from pars plana vitrectomy versus combined pars plana vitrectomy, phacoemulsification, and intraocular lens implantation in patients with diabetes.
    Silva PS; Diala PA; Hamam RN; Arrigg PG; Shah ST; Murtha TL; Schlossman DK; Cavallerano JD; Sun JK; Aiello LP
    Retina; 2014 Oct; 34(10):1960-8. PubMed ID: 24830822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone].
    Naser H; Koss MJ; Singh P; Koch F
    Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avastin as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy: a prospective case series.
    Yeoh J; Williams C; Allen P; Buttery R; Chiu D; Clark B; Essex R; McCombe M; Qureshi S; Campbell WG
    Clin Exp Ophthalmol; 2008 Jul; 36(5):449-54. PubMed ID: 18942219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-silicone oil injection of methotrexate at the end of vitrectomy for advanced proliferative diabetic retinopathy.
    Ghasemi Falavarjani K; Modarres M; Hadavandkhani A; Karimi Moghaddam A
    Eye (Lond); 2015 Sep; 29(9):1199-203. PubMed ID: 26160528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
    Douglas MJ; Scott IU; Flynn HW
    Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
    Jonas JB; Söfker A; Degenring R
    Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epiretinal membrane formation after pars plana vitrectomy in proliferative diabetic retinopathy].
    Messmer E; Bornfeld N; Oehlschläger U; Heinrich T; Foerster MH; Wessing A
    Klin Monbl Augenheilkd; 1992 Apr; 200(4):267-72. PubMed ID: 1614088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
    Nisic F; Gadzo AP; Fajkic A; Nisic A; Miokovic AP; Damjanovic G; Begic E; Beslic N; Lepara O
    Rom J Ophthalmol; 2023; 67(3):283-288. PubMed ID: 37876512
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
    Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
    Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
    Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
    Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
    Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M
    Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.